Total planned funding: $1,209,567,776
Clear active filters
South Africa
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $1,209,567,776 |
Organizational Types
NGO | $553,294,291 |
Implementing Agency | $417,185,533 |
Own Agency | $73,763,296 |
Unknown | $56,098,703 |
University | $41,023,132 |
Private Contractor | $38,419,554 |
FBO | $8,630,000 |
Multi-lateral Agency | $7,766,700 |
Parastatal | $7,470,979 |
Other USG Agency | $3,931,588 |
Host Country Government Agency | $1,984,000 |
Program Areas
Treatment | $645,595,670 |
Care | $250,999,725 |
Prevention | $216,116,811 |
Testing | $56,782,563 |
Management and Operations | $26,207,496 |
Governance and Systems | $13,865,511 |
Budget Codes
HTXS: Treatment: Adult Treatment | $609,819,058 |
HVOP: Sexual Prevention: Other Sexual Prevention | $102,443,409 |
HVTB: Care: TB/HIV | $100,479,617 |
HKID: Care: Orphans and Vulnerable Children | $77,291,790 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $71,983,905 |
HVCT: Testing: HIV Testing and Counseling | $56,782,563 |
HBHC: Care: Adult Care and Support | $50,259,537 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $27,134,357 |
HVMS: Management and Operations | $26,207,496 |
PDTX: Treatment: Pediatric Treatment | $24,016,081 |
PDCS: Care: Pediatric Care and Support | $22,968,781 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,255,850 |
HTXD: Treatment: ARV Drugs | $11,760,531 |
HLAB: Laboratory Infrastructure | $7,003,986 |
HVSI: Strategic Information | $4,433,433 |
OHSS: Health Systems Strengthening | $2,428,092 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,299,290 |
Top Partner Programs
Anova Health Institute:
$148,485,550
Countries/Regions
South Africa
2019 | $93,444,780 |
2020 | $55,040,770 |
University of the Witwatersrand:
$143,388,803
Countries/Regions
South Africa
2019 | $94,986,602 |
2020 | $48,402,201 |